Suchergebnisse - "Hooper, Andrea T"

PubPharm (88)

1

Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection

enthalten in: Open forum infectious diseases | 2023

von Xu, M. | O'Brien, M. | Hooper, A. | +10

2

Casirivimab + imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles

enthalten in: Scientific reports | 2023

von Li, D. | Xu, M. | Hooper, A. | +9

3

Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration

enthalten in: Nature communications | 2023

von Follmann, D. | O'Brien, M. | Fintzi, J. | +21

4

Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019 : A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial

enthalten in: Open forum infectious diseases | 2023

von Somersan-Karakaya, S. | Mylonakis, E. | Mou, J. | +14

5

Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19

enthalten in: The Journal of infectious diseases | 2022

von Somersan-Karakaya, S. | Mylonakis, E. | Menon, V. | +31

6

Casirivimab and Imdevimab Treatment Reduces Viral Load and Improves Clinical Outcomes in Seropositive Hospitalized COVID-19 Patients with Nonneutralizing or Borderline Neutralizing Antibodies

enthalten in: mBio | 2022

von Hooper, A. | Somersan-Karakaya, S. | McCarthy, S. | +12

7

Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period : a randomised, double-blind, placebo-controlled trial

enthalten in: The Lancet. Infectious diseases | 2022

von Herman, G. | O'Brien, M. | Forleo-Neto, E. | +127

CommentIn: Lancet Infect Dis. 2022 Oct;22(10):1400-1401. - PMID 35803288

8

Evaluation of EDB Fibronectin in Plasma, Patient-Derived Xenograft Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tumor Tissues Using Immunoaffinity LC-MS/MS

enthalten in: Journal of proteome research | 2022

von Li, F. | Hooper, A. | Golas, J. | +3

9

Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022

von Isa, F. | Forleo-Neto, E. | Meyer, J. | +28

10

Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade

enthalten in: Molecular cancer therapeutics | 2022

von Hooper, A. | Marquette, K. | Chang, C. | +21

1
2
3
4
5
6
7
8
9
Nächster »
[9]